Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Cocoa polyphenols can increase calmness and contentedness

by Eric W. Dolan
April 22, 2013
in Psychopharmacology
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Dark chocolate by John LooResearch to be published in the May issue of the Journal of Psychopharmacology has found cocoa polyphenols have a positive impact on mood in healthy individuals.

“To our knowledge, this is the first randomized, controlled trial to substantiate the effects of cocoa polyphenols on positive mood states in a non-clinical sample,” Matthew P. Pase of Swinburne University in Australia and his colleagues wrote in their study.

“Future research is needed to investigate whether cocoa polyphenols can ameliorate the symptoms associated with clinical anxiety or depression.”

The group of compounds are found naturally in the cocoa bean, the main constituent of dark chocolate. Many people believe consuming dark chocolate reduces anxiety and some research has even found that dark chocolate could improve mental functioning.

In the study of 72 healthy men and women aged 40–65 years, those who consumed a large amount of cocoa polyphenols in the form of a dark chocolate drink mix reported greater calmness and contentedness than those who consumed a chocolate drink mix that lacked polyphenols. The participants in the study maintained a relatively strict diet for 30 days to avoid consuming additional polyphenols.

The researchers failed to find any evidence that cocoa polyphenols significantly improved cognitive performance. Additionally, only those who consumed the highest amount of polyphenols (500 mg per day) reported any significant positive effects. Participants who consumed a moderate amount (250 mg per day) reported no significant effects.

Previous research suggests that cocoa polyphenols produce anti-anxiety effects by interacting with GABA receptors in the brain, Pase and his colleagues explained.

“Given the known actions of polyphenols on GABAa receptors, further human clinical trials are needed to substantiate the effects of cocoa polyphenols on anxiety and calmness.”

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Cannabis

Regular cannabis use linked to changes in brain activity regulating movement

June 20, 2025

Researchers have discovered that frequent cannabis users show reduced spontaneous brain activity in the motor cortex, and this neural suppression is tied to cannabis use severity and response speed, even though overall task performance remained comparable to non-users.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Addiction

Scientists map how alcohol changes bodily sensations

June 14, 2025

A new study suggests that people who feel fewer bodily sensations while intoxicated may be at higher risk for alcohol misuse. Using bodily maps and heartbeat tasks, researchers linked internal awareness to physiological effects and subjective feelings of intoxication.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Exposure to heavy metals is associated with higher likelihood of ADHD diagnosis

Eye-tracking study shows people fixate longer on female aggressors than male ones

Romantic breakups follow a two-stage decline that begins years before the split, study finds

Believing “news will find me” is linked to sharing fake news, study finds

A common parasite not only invades the brain — it can also decapitate human sperm

Almost all unmarried pregant women say that the fetus resembles the father, study finds

New neuroscience research reveals brain antioxidant deficit in depression

Scientists uncover kidney-to-brain route for Parkinson’s-related protein spread

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy